Population Genomics of Reduced Vancomycin Susceptibility in Staphylococcus aureus.
about
Novel Mutation Sites in the Development of Vancomycin- Intermediate Resistance in Staphylococcus aureus.Antimicrobial resistance in healthcare, agriculture and the environment: the biochemistry behind the headlines.Use of bacterial whole-genome sequencing to understand and improve the management of invasive Staphylococcus aureus infections.Genomic exploration of sequential clinical isolates reveals a distinctive molecular signature of persistent Staphylococcus aureus bacteraemia
P2860
Population Genomics of Reduced Vancomycin Susceptibility in Staphylococcus aureus.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Population Genomics of Reduced Vancomycin Susceptibility in Staphylococcus aureus.
@en
type
label
Population Genomics of Reduced Vancomycin Susceptibility in Staphylococcus aureus.
@en
prefLabel
Population Genomics of Reduced Vancomycin Susceptibility in Staphylococcus aureus.
@en
P2860
P356
P1433
P1476
Population Genomics of Reduced Vancomycin Susceptibility in Staphylococcus aureus
@en
P2093
Colleen S Kraft
I King Jordan
P2860
P356
10.1128/MSPHERE.00094-16
P577
2016-07-20T00:00:00Z